Stock Market ETFs & Funds Bonds & Rates Commodities Cryptocurrency Forex U.S. Canada Earnings Inflation China Fed Bitcoin (BTC) Tech Currencies Energy U.K. Coronavirus Europe Tesla (TSLA) Natural Gas Australia Economy Ethereum (ETH) Wall Street Money Business Twitter (TWTR) Gold Nasdaq 100 Japan Elon Musk Taxes Apple (AAPL) Amazon (AMZN) S&P 500 Finance Blockchain Meta Platforms (META) Investing Dividend Germany EUR USD NFT Cars Health NYSE Crude Oil Retirement SEC Mining Asia GBP USD Netflix (NFLX) Microsoft (MSFT) France Dow 30 (DJI) Binance Coinbase USD JPY Walt Disney (DIS) Stablecoins Manufacturing Goldman Sachs (GS) IPOs AUD USD Italy Real Estate JPMorgan (JPM) Shanghai XAU USD Terra (LUNA) NVIDIA (NVDA) Solana (SOL) Morgan Stanley (MS) Ford Motor (F) DeFi Dogecoin (DOGE) Warren Buffett Dollar Index Boeing (BA) Cardano (ADA) USD CAD Personal Finance Google FOMC Insurance Banking Environment REITs Alibaba (BABA) Wealth Ripple (XRP) Walmart (WMT) Intel (INTC) Bank of America (BAC) Silver South Korea Cannabis Copper AMD (AMD) NZD USD Wells Fargo&Co (WFC) Loans FTSE 100 SPDR S&P 500 ETF TrustMore + Contact
The Stock Market News
     

New Patent Lawsuit Adds to Litigation Worries for Moderna Stock – Barron’s

Barron's

New Patent Lawsuit Adds to Litigation Worries for Moderna Stock  Barron’s

Moderna (MRNA)
11 months

Personalis and Moderna Sign New Agreement to Leverage NeXT Platform(TM) in Personalized mRNA Cancer Vaccine Clinical Trials – Barron’s

Barron's
2 days

China’s CanSino confident its mRNA COVID vaccine as good as Moderna, Pfizer shots

Financial Post
2 days

China’s CanSino confident its mRNA COVID vaccine as good as … – Reuters

Reuters
2 days

Is Moderna Stock a Buy Now? – The Motley Fool

The Motley Fool
2 days

BioNTech to invest $43 mln in German facility for mRNA vaccine … – Reuters

Reuters
3 days

Arcturus’ mRNA Platform: The Future Of Quick And Efficient Vaccine Delivery

Seeking Alpha
4 days

Moderna’s stock is down as Pfizer lowers revenue estimates for its … – Morningstar

Morningstar
5 days

The end of the Covid health emergency won’t slow FDA clearance of shots and treatments

CNBC
5 days

Is Moderna (MRNA) a High Growth Stock?

Insider Monkey
6 days

Moderna Scores A Win In RSV — But Its Shares Don’t Reflect That

Investor's Business Daily
6 days

Moderna’s RSV vaccine gets Breakthrough Therapy status – Morningstar

Morningstar
6 days

Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip

Investor's Business Daily
1 week

FDA advisors recommend replacing original Covid vaccine with bivalent omicron shots for all doses

CNBC
1 week

Hedge Fund and Insider Trading News: Anthony Scaramucci, Brummer & Partners, Elliott Management, Waratah Capital Advisors, Oasis Management, BancFirst Corp (BANF), Moderna, Inc. (MRNA), and More

Insider Monkey
2 weeks

Could This RSV News Make Moderna a Hot Buy Again? – The Motley Fool

The Motley Fool
2 weeks

5 Most Undervalued NASDAQ Stocks To Buy According To Hedge Funds

Insider Monkey
2 weeks

Fact Check-No evidence COVID-19 mRNA vaccines are significant … – Reuters

Reuters
2 weeks

Moderna Hiring and a Proposed TikTok Ban

Bloomberg
2 weeks

An Annual Covid Booster May Be Coming. What It Means for Pfizer and Moderna. – Barron’s

Barron's
2 weeks

Sinopharm unit gets OK for clinical trials of mRNA COVID vaccine – Reuters

Reuters
2 weeks

CureVac Stock Just Got Upgraded. It’s Now a Competitor in mRNA Vaccines. – Barron’s

Barron's
2 weeks
CureVac Can Finally Compete With Moderna. It’s an ‘Under-the-Radar mRNA Story.’

CureVac Can Finally Compete With Moderna. It’s an ‘Under-the-Radar mRNA Story.’

Yahoo Finance
2 weeks

UBS: CureVac has a ‘potentially competitive mRNA platform’ – Morningstar

Morningstar
2 weeks

Kaneka expands GMP manufacturing capacity for mRNA in Kaneka Eurogentec S.A.

Financial Post
3 weeks

Three-Stock Lunch: MRNA, SCHW & KHC

YouTube
3 weeks
Read more financial news

The Stock Market News

Financial news aggregator for traders and investors that proposes to you the latest financial news, business top stories, today's headlines, trading analysis, opinions and forecasts on stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs & funds, bonds & rates and much more. We do not create or publish our own content or copy full articles from other sites. The Stock Market News works with public RSS feeds of best business, finance and economic news websites, personal blogs and provides automatically generated list of financial news links directly referring to its sources.

Facebook | Twitter | RSS | Contact

© 2023 The Stock Market News